Delivery Order SPE2DB20D2002-SPE2DB26FK99E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count) with a contract value of $15,742.28. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 6, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $5,359.73. This non-competitive delivery order is set to be completed by August 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count packaging) with a contract value of $2,242.17 and an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entresto 97mg-103mg tablets (60-count) on September 17, 2025, with a ceiling value of $2,242.17 and ultimate completion date of September 18, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed price contracting and represents a small pharmaceutical procurement supporting federal medical supply needs. The order will be fulfilled from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-unit quantity) valued at $1,476.42. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 27, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units) with a ceiling value of $3,452.83. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is expected to be completed by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) at a ceiling value of $6,077.44. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The order is due for completion by April 24, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $6,279.78 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Entresto 49 mg-51 mg tablets in a quantity of 180 units, with a firm fixed price ceiling value of $10,611.73. This delivery order was competitively awarded with no set-aside designation and is expected to be completed by June 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB26FK99EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) valued at $2,151.36. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Entresto delivery represents a routine pharmaceutical supply order consistent with the company's extensive portfolio of medications across multiple therapeutic domains supporting defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/23/25 |